Pendal Group’s Halozyme HALO Stock Holding History

Pendal Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,500	Closed	-$271K	–	579
2021 Q1	$271K	Buy	+6,500	New	+$297K	﹤0.01%	503

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pendal Group's HALO Position: Q2 2021 in Review

Pendal Group sold out of Halozyme (HALO) in Q2 2021, closing a stake of 6,500 shares — an estimated $271K sold.

Pendal Group first reported a position in HALO in Q1 2021 and held it in 1 quarter. The position peaked at $271K in Q1 2021. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

Pendal Group reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
Pendal Group sold 6,500 Halozyme shares in Q2 2021, an estimated $271K.
Pendal Group first reported a position in Halozyme in Q1 2021 and held it in 1 quarter.
Pendal Group's Halozyme position peaked at $271K in Q1 2021.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Pendal Group's 13F filing for Q2 2021, filed 28 Jul 2021.